Not your institution?

Works by Asselah, Tarik

Results: 86
    1
    2

    Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1: pooled analysis of two phase 3 trials.

    Published in:
    Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2016, v. 15, n. 3, p. 333, doi. 10.5604/16652681.1198803
    By:
    • Jensen, Donald M.;
    • Asselah, Tarik;
    • Dieterich, Douglas;
    • Foster, Graham R.;
    • Sulkowski, Mark S.;
    • Zeuzem, Stefan;
    • Mantry, Parvez;
    • Yoshida, Eric M.;
    • Moreno, Christophe;
    • Ouzan, Denis;
    • Wright, Mark;
    • Morano, Luis E.;
    • Buynak, Robert;
    • Bourlière, Marc;
    • Hassanein, Tarek;
    • Nishiguchi, Shuhei;
    • Jia-Horng Kao;
    • Masao Omata;
    • Paik, Seung W.;
    • Wong, David K.
    Publication type:
    Article
    3
    4

    Evolution of Hepatitis C Virus Treatment During the Era of Sofosbuvir-Based Therapies: A Real-World Experience in France.

    Published in:
    Digestive Diseases & Sciences, 2021, v. 66, n. 3, p. 881, doi. 10.1007/s10620-020-06234-1
    By:
    • Ouzan, Denis;
    • Larrey, Dominique;
    • Guyader, Dominique;
    • Remy, André-Jean;
    • Riachi, Ghassan;
    • Heluwaert, Fréderic;
    • Truchi, Régine;
    • Combis, Jean-Marc;
    • Bailly, François;
    • Rosa, Isabelle;
    • Hézode, Christophe;
    • Glorian-Petraud, Denise;
    • Libert, Olivier;
    • Ramroth, Heribert;
    • Asselah, Tarik;
    • Thiefin, Gérard;
    • Roulot, Dominique;
    • Roche, Bruno;
    • Leroy, Vincent;
    • Dumortier, Jérôme
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11

    Deferred treatment with a fixed‐dose combination of sofosbuvir‐velpatasvir for chronic hepatitis C virus genotype 1, 2, 4 and 6 infection.

    Published in:
    Journal of Viral Hepatitis, 2019, v. 26, n. 10, p. 1229, doi. 10.1111/jvh.13159
    By:
    • Asselah, Tarik;
    • Shafran, Stephen D.;
    • Bourgeois, Stefan;
    • Lai, Ching‐Lung;
    • Mathurin, Philippe;
    • Willems, Bernard;
    • Nguyen, Mindie H.;
    • Davis, Mitchell N.;
    • Huang, K. C.;
    • Svarovskaia, Evguenia;
    • Osinusi, Anu;
    • McNally, John;
    • Brainard, Diana M.;
    • Shaikh, Obaid S.;
    • Tran, Tram T.
    Publication type:
    Article
    12
    13

    Abdominal pain in a 22 year old woman.

    Published in:
    Postgraduate Medical Journal, 2000, p. 583, doi. 10.1136/pmj.76.899.583
    By:
    • Asselah, Tarik;
    • Ernst, Olivier;
    • Canva, Valérie;
    • Paris, Jean-Claude
    Publication type:
    Article
    14
    15

    Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis.

    Published in:
    BMC Infectious Diseases, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12879-022-07076-0
    By:
    • Pageaux, Georges-Philippe;
    • Nzinga, Clovis Lusivika;
    • Ganne, Nathalie;
    • Samuel, Didier;
    • Dorival, Céline;
    • Zoulim, Fabien;
    • Cagnot, Carole;
    • Decaens, Thomas;
    • Thabut, Dominique;
    • Asselah, Tarik;
    • Mathurin, Philippe;
    • Habersetzer, François;
    • Bronowicki, Jean-Pierre;
    • Guyader, Dominique;
    • Rosa, Isabelle;
    • Leroy, Vincent;
    • Chazouilleres, Olivier;
    • de Ledinghen, Victor;
    • Bourliere, Marc;
    • Causse, Xavier
    Publication type:
    Article
    16

    Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis.

    Published in:
    BMC Infectious Diseases, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12879-022-07076-0
    By:
    • Pageaux, Georges-Philippe;
    • Nzinga, Clovis Lusivika;
    • Ganne, Nathalie;
    • Samuel, Didier;
    • Dorival, Céline;
    • Zoulim, Fabien;
    • Cagnot, Carole;
    • Decaens, Thomas;
    • Thabut, Dominique;
    • Asselah, Tarik;
    • Mathurin, Philippe;
    • Habersetzer, François;
    • Bronowicki, Jean-Pierre;
    • Guyader, Dominique;
    • Rosa, Isabelle;
    • Leroy, Vincent;
    • Chazouilleres, Olivier;
    • de Ledinghen, Victor;
    • Bourliere, Marc;
    • Causse, Xavier
    Publication type:
    Article
    17
    18
    19

    Final analysis of the international observational S-Collate study of peginterferon alfa-2a in patients with chronic hepatitis B.

    Published in:
    PLoS ONE, 2020, v. 15, n. 4, p. 1, doi. 10.1371/journal.pone.0230893
    By:
    • Marcellin, Patrick;
    • Xie, Qing;
    • Woon Paik, Seung;
    • Flisiak, Robert;
    • Piratvisuth, Teerha;
    • Petersen, Jörg;
    • Asselah, Tarik;
    • Cornberg, Markus;
    • Ouzan, Denis;
    • Foster, Graham R.;
    • Papatheodoridis, Georgios;
    • Messinger, Diethelm;
    • Regep, Loredana;
    • Bakalos, Georgios;
    • Alshuth, Ulrich;
    • Lampertico, Pietro;
    • Wedemeyer, Heiner
    Publication type:
    Article
    20
    21
    22
    23
    24

    Corrigendum.

    Published in:
    2021
    By:
    • Pol, Stanislas;
    • Luzivika Nzinga, Clovis;
    • Dorival, Céline;
    • Zoulim, Fabien;
    • Cagnot, Carole;
    • Decaens, Thomas;
    • Thabut, Dominique;
    • Asselah, Tarik;
    • Mathurin, Philippe;
    • Ganne, Nathalie;
    • Samuel, Didier;
    • Habersetzer, François;
    • Bronowicki, Jean‐Pierre;
    • Guyader, Dominique;
    • Rosa, Isabelle;
    • Leroy, Vincent;
    • Chazouilleres, Olivier;
    • De Ledinghen, Victor;
    • Bourliere, Marc;
    • Causse, Xavier
    Publication type:
    Correction Notice
    25
    26

    miRNAs as Potential Biomarkers for Viral Hepatitis B and C.

    Published in:
    Viruses (1999-4915), 2020, v. 12, n. 12, p. 1440, doi. 10.3390/v12121440
    By:
    • Loureiro, Dimitri;
    • Tout, Issam;
    • Narguet, Stéphanie;
    • Benazzouz, Sabrina Menasria;
    • Mansouri, Abdellah;
    • Asselah, Tarik;
    • Yelamanchili, Sowmya V.;
    • Witwer, Kenneth W.
    Publication type:
    Article
    27
    28
    29
    30

    Efficacy of a 12-Week Simeprevir Plus Peginterferon/Ribavirin (PR) Regimen in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection and Mild-To-Moderate Fibrosis Displaying Early On-Treatment Virologic Response.

    Published in:
    PLoS ONE, 2017, v. 12, n. 1, p. 1, doi. 10.1371/journal.pone.0168713
    By:
    • Asselah, Tarik;
    • Moreno, Christophe;
    • Sarrazin, Christoph;
    • Gschwantler, Michael;
    • Foster, Graham R.;
    • Craxí, Antonio;
    • Buggisch, Peter;
    • Sanai, Faisal;
    • Bicer, Ceyhun;
    • Lenz, Oliver;
    • Van Dooren, Gino;
    • Nalpas, Catherine;
    • Lonjon-Domanec, Isabelle;
    • Schlag, Michael;
    • Buti, Maria
    Publication type:
    Article
    31
    32
    33
    34

    Metabolic Disorders in Patients with Chronic Hepatitis B Virus Infection: Coffee as a Panacea? (ANRS CO22 Hepather Cohort).

    Published in:
    Antioxidants, 2022, v. 11, n. 2, p. 379, doi. 10.3390/antiox11020379
    By:
    • Barré, Tangui;
    • Fontaine, Hélène;
    • Pol, Stanislas;
    • Ramier, Clémence;
    • Di Beo, Vincent;
    • Protopopescu, Camelia;
    • Marcellin, Fabienne;
    • Bureau, Morgane;
    • Bourlière, Marc;
    • Dorival, Céline;
    • Petrov-Sanchez, Ventzislava;
    • Asselah, Tarik;
    • Delarocque-Astagneau, Elisabeth;
    • Larrey, Dominique;
    • Duclos-Vallée, Jean-Charles;
    • Carrat, Fabrice;
    • Carrieri, Patrizia
    Publication type:
    Article
    35

    Éducation thérapeutique et hépatites: une nouvelle écologie du patient, «le parcours de soin». Un exemple avec le réseau REVHEPAT.

    Published in:
    Hépato-Gastro & Oncologie Digestive, 2017, v. 24, n. 2, p. 112, doi. 10.1684/hpg.2017.1409
    By:
    • Boyer, Nathalie;
    • Aurières, Christine;
    • Monnier, Béatrice;
    • Bouton, Valérie;
    • Cattan, Laurent;
    • De Freitas, Cecilia;
    • Giuily, Nathalie;
    • Castelnau, Corinne;
    • Sitruk, Véronique;
    • Abazid, Malek;
    • Asselah, Tarik;
    • Marcellin, Patrick;
    • Kerjean, Nathalie Pons
    Publication type:
    Article
    36

    Updated Results from the Retrospective CREST Study on the Safety and Effectiveness of 8-Week Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis.

    Published in:
    Advances in Therapy, 2024, v. 41, n. 12, p. 4669, doi. 10.1007/s12325-024-02996-6
    By:
    • Cornberg, Markus;
    • Hüppe, Dietrich;
    • Sarrazin, Christoph;
    • Ahumada, Adriana;
    • Jorquera Plaza, Francisco;
    • Mariño, Zoe;
    • Otano, Juan Isidro Uriz;
    • Conway, Brian;
    • Myles, Lindsay;
    • Ramji, Alnoor;
    • Abergel, Armand;
    • Asselah, Tarik;
    • Larrey, Dominique;
    • Aghemo, Alessio;
    • Andreoni, Massimo;
    • Gasbarrini, Antonio;
    • Lampertico, Pietro;
    • Persico, Marcello;
    • Villa, Erica;
    • Carmiel, Michal
    Publication type:
    Article
    37
    38

    Ombitasvir/paritaprevir/ritonavir plus ribavirin for 24 weeks in patients with HCV GT4 and compensated cirrhosis (AGATE‐I Part II).

    Published in:
    Health Science Reports, 2019, v. 2, n. 3, p. N.PAG, doi. 10.1002/hsr2.92
    By:
    • Asselah, Tarik;
    • Alami, Negar Niki;
    • Moreno, Christophe;
    • Pol, Stanislas;
    • Karatapanis, Stylianos;
    • Gschwantler, Michael;
    • Horsmans, Yves;
    • Elefsiniotis, Ioannis;
    • Larrey, Dominique;
    • Ferrari, Carlo;
    • Rizzetto, Mario;
    • Orlandini, Alessandra;
    • Calleja, Jose Luis;
    • Bruno, Savino;
    • Schnell, Gretja;
    • Qaqish, Roula;
    • Redman, Rebecca;
    • Pilot‐Matias, Tami;
    • Kopecky‐Bromberg, Sarah;
    • Yu, Yao
    Publication type:
    Article
    39

    Hepatitis D Virus Infection: Pathophysiology, Epidemiology and Treatment. Report From the Third Delta Cure Meeting 2024.

    Published in:
    Liver International, 2025, v. 45, n. 7, p. 1, doi. 10.1111/liv.70189
    By:
    • Degasperi, Elisabetta;
    • Sandmann, Lisa;
    • Wedemeyer, Heiner;
    • Lampertico, Pietro;
    • Agarwal, Kosh;
    • Aleman, Soo;
    • Allweiss, Lena;
    • Anolli, Maria Paola;
    • Asselah, Tarik;
    • Berg, Thomas;
    • Brunetto, Maurizia;
    • Buti, Maria;
    • Chemin, Isabelle;
    • D'Offizi, Gianpiero;
    • Dahari, Harel;
    • Dandri, Maura;
    • Esteban, Rafael;
    • Fontaine, Hélène;
    • Hamid, Saeed Sadiq;
    • Jachs, Mathias
    Publication type:
    Article
    40
    41

    Behaviour‐Based Predictive Scores of Hepatocellular Carcinoma in People With Chronic Hepatitis B (ANRS CO22 HEPATHER).

    Published in:
    Liver International, 2025, v. 45, n. 4, p. 1, doi. 10.1111/liv.70065
    By:
    • Ramier, Clémence;
    • Protopopescu, Camelia;
    • Di Beo, Vincent;
    • Parlati, Lucia;
    • Marcellin, Fabienne;
    • Carrat, Fabrice;
    • Asselah, Tarik;
    • Bourlière, Marc;
    • Carrieri, Patrizia;
    • Alric, Laurent;
    • Bonnet, Delphine;
    • Camou, Océane;
    • Zoulim, Fabien;
    • Maynard, Marianne;
    • Bailly, François;
    • Poumaroux, Bénédicte;
    • Subic, Miroslava;
    • Raffi, François;
    • Billaud, Eric;
    • Boutoille, David
    Publication type:
    Article
    42

    Bulevirtide Monotherapy Is Safe and Well Tolerated in Chronic Hepatitis Delta: An Integrated Safety Analysis of Bulevirtide Clinical Trials at Week 48.

    Published in:
    Liver International, 2025, v. 45, n. 4, p. 1, doi. 10.1111/liv.16174
    By:
    • Asselah, Tarik;
    • Lampertico, Pietro;
    • Aleman, Soo;
    • Bourlière, Marc;
    • Streinu‐Cercel, Adrian;
    • Bogomolov, Pavel;
    • Morozov, Viacheslav;
    • Stepanova, Tatiana;
    • Lazar, Stefan;
    • Manuilov, Dmitry;
    • Mercier, Renee‐Claude;
    • Tseng, Steve;
    • Ye, Lei;
    • Flaherty, John F.;
    • Osinusi, Anu;
    • Da, Ben L.;
    • Chee, Grace M.;
    • Lau, Audrey H.;
    • Brunetto, Maurizia R.;
    • Wedemeyer, Heiner
    Publication type:
    Article
    43

    Direct Antivirals Can Achieve a Cure in All Patients With Chronic Hepatitis C due to Genotype 5: A French Multicentre Study.

    Published in:
    Liver International, 2025, v. 45, n. 4, p. 1, doi. 10.1111/liv.16158
    By:
    • Nicolas, Carine;
    • Domas, Quentin;
    • Pol, Stanislas;
    • Bardou‐Jacquet, Edouard;
    • Loustaud‐Ratti, Véronique;
    • Métivier, Sophie;
    • Asselah, Tarik;
    • Thabut, Dominique;
    • Bourlière, Marc;
    • Mathurin, Philippe;
    • Foucher, Juliette;
    • Larrey, Dominique;
    • Varaut, Anne;
    • Alric, Laurent;
    • Bailly, François;
    • Muti, Léon;
    • Buchard, Benjamin;
    • Abergel, Armando
    Publication type:
    Article
    44
    45

    Early virological response in six patients with hepatitis D virus infection and compensated cirrhosis treated with Bulevirtide in real‐life.

    Published in:
    Liver International, 2021, v. 41, n. 7, p. 1509, doi. 10.1111/liv.14950
    By:
    • Asselah, Tarik;
    • Loureiro, Dimitri;
    • Le Gal, Fréderic;
    • Narguet, Stéphanie;
    • Brichler, Ségolène;
    • Bouton, Valérie;
    • Abazid, Malek;
    • Boyer, Nathalie;
    • Giuly, Nathalie;
    • Gerber, Athenais;
    • Tout, Issam;
    • Maylin, Sarah;
    • Bed, Cheikh M.;
    • Marcellin, Patrick;
    • Castelnau, Corinne;
    • Gordien, Emmanuel;
    • Mansouri, Abdellah
    Publication type:
    Article
    46

    New therapies for hepatitis delta virus infection.

    Published in:
    Liver International, 2021, v. 41, p. 30, doi. 10.1111/liv.14838
    By:
    • Loureiro, Dimitri;
    • Castelnau, Corinne;
    • Tout, Issam;
    • Boyer, Nathalie;
    • Narguet, Stéphanie;
    • Menasria Benazzouz, Sabrina;
    • Louis, Zeina;
    • Pons‐Kerjean, Nathalie;
    • Giuly, Nathalie;
    • Marcellin, Patrick;
    • Mansouri, Abdellah;
    • Asselah, Tarik;
    • Valenti, Luca
    Publication type:
    Article
    47

    Efficacy and safety of glecaprevir/pibrentasvir in patients with HCV genotype 5/6: An integrated analysis of phase 2/3 studies.

    Published in:
    Liver International, 2020, v. 40, n. 10, p. 2385, doi. 10.1111/liv.14535
    By:
    • Yao, Betty B.;
    • Fredrick, Linda M.;
    • Schnell, Gretja;
    • Kowdley, Kris V.;
    • Kwo, Paul Y.;
    • Poordad, Fred;
    • Nguyen, Kinh;
    • Lee, Samuel S.;
    • George, Christophe;
    • Wong, Florence;
    • Gane, Edward;
    • Abergel, Armand;
    • Spearman, Catherine W.;
    • Nguyen, Tuan;
    • Hung Le, Manh;
    • Pham, Thuy TT.;
    • Mensa, Federico;
    • Asselah, Tarik;
    • Dore, Gregory
    Publication type:
    Article
    48

    Phase 3, Multicenter Open‐Label study to investigate the efficacy of elbasvir and grazoprevir fixed‐dose combination for 8 weeks in treatment‐naïve, HCV GT1b‐infected patients, with non‐severe fibrosis.

    Published in:
    Liver International, 2020, v. 40, n. 8, p. 1853, doi. 10.1111/liv.14502
    By:
    • Abergel, Armand;
    • Asselah, Tarik;
    • Mallat, Arianne;
    • Chanteranne, Brigitte;
    • Faure, Frederic;
    • Larrey, Dominique;
    • Gournay, Jerome;
    • Loustaud‐Ratti, Veronique;
    • Di Martino, Vincent;
    • Fouchard‐Hubert, Isabelle;
    • Pol, Stanislas;
    • Bailly, Francois;
    • Samuel, Didier;
    • Tran, Albert;
    • Dodel, Marie;
    • Andant, Nicolas;
    • Lamblin, Geraldine;
    • Muti, Leon;
    • Reymond, Maud;
    • Teilhet, Camille
    Publication type:
    Article
    49

    Efficacy and safety of elbasvir/grazoprevir for 8 or 12 weeks for hepatitis C virus genotype 4 infection: A randomized study.

    Published in:
    Liver International, 2020, v. 40, n. 5, p. 1042, doi. 10.1111/liv.14313
    By:
    • Asselah, Tarik;
    • Pol, Stanislas;
    • Hezode, Christophe;
    • Loustaud‐Ratti, Veronique;
    • Leroy, Vincent;
    • Ahmed, Si Nafa Si;
    • Ozenne, Violaine;
    • Bronowicki, Jean‐Pierre;
    • Larrey, Dominique;
    • Tran, Albert;
    • Alric, Laurent;
    • Nguyen‐Khac, Eric;
    • Robertson, Michael N.;
    • Hanna, George J.;
    • Brown, Deborah;
    • Asante‐Appiah, Ernest;
    • Su, Feng‐Hsiu;
    • Hwang, Peggy;
    • Hall, Jessie Durrand;
    • Guidoum, Amir
    Publication type:
    Article
    50